Page 17 - Read Online
P. 17

Kikukawa et al. Microbiome Res Rep 2023;2:4  https://dx.doi.org/10.20517/mrr.2022.24  Page 11 of 12

               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2023.


               REFERENCES
               1.       Turroni F, Sinderen D, Ventura M. Genomics and ecological overview of the genus Bifidobacterium. Int J Food Microbiol
                   2011;149:37-44.  DOI  PubMed
               2.       Fushinobu S. Unique sugar metabolic pathways of bifidobacteria. Biosci Biotechnol Biochem 2010;74:2374-84.  DOI  PubMed
               3.       Sharma M, Wasan A, Sharma RK. Recent developments in probiotics: an emphasis on Bifidobacterium. Food Biosci 2021;41:100993.
                   DOI
               4.       Kelly SM, Munoz-Munoz J, van Sinderen D. Plant glycan metabolism by Bifidobacteria. Front Microbiol 2021;12:609418.  DOI
                   PubMed  PMC
               5.       Sakanaka M, Gotoh A, Yoshida K, et al. Varied pathways of infant gut-associated Bifidobacterium to assimilate human milk
                   oligosaccharides: prevalence of the gene set and its correlation with bifidobacteria-rich microbiota formation. Nutrients 2019;12:71.
                   DOI  PubMed  PMC
               6.       Sakanaka M, Hansen ME, Gotoh A, et al. Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant
                   symbiosis. Sci Adv 2019;5:eaaw7696.  DOI  PubMed  PMC
               7.       Martinez FA, Balciunas EM, Converti A, Cotter PD, de Souza Oliveira RP. Bacteriocin production by Bifidobacterium spp. a review.
                   Biotechnol Adv 2013;31:482-8.  DOI  PubMed
               8.       Zavaglia A, Kociubinski G, Pérez P, Disalvo E, De Antoni G. Effect of bile on the lipid composition and surface properties of
                   bifidobacteria. J Appl Microbiol 2002;93:794-9.  DOI  PubMed
               9.       Mawatari S, Sasuga Y, Morisaki T, et al. Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium
                   animalis. Sci Rep 2020;10:427.  DOI
               10.      Fontes AL, Pimentel L, Rodríguez-Alcalá LM, Gomes A. Effect of pufa substrates on fatty acid profile of Bifidobacterium breve
                   Ncimb 702258 and CLA/CLNA production in commercial semi-skimmed milk. Sci Rep 2018;8:15591.  DOI  PubMed  PMC
               11.      Liu S, Ren F, Jiang J, Zhao L. Acid response of Bifidobacterium longum subsp. longum BBMN68 is accompanied by modification of
                   the cell membrane fatty acid composition. J Microbiol Biotechnol 2016;26:1190-7.  DOI  PubMed
               12.      O'Connell KJ, Motherway MO, Hennessey AA, et al. Identification and characterization of an oleate hydratase-encoding gene from
                   Bifidobacterium breve. Bioengineered 2013;4:313-21.  DOI  PubMed  PMC
               13.      Veerkamp JH. Fatty acid composition of Bifidobacterium and Lactobacillus strains. J Bacteriol 1971;108:861-7.  DOI  PubMed  PMC
               14.      Argudín M, Mendoza MC, Rodicio MR. Food poisoning and Staphylococcus aureus enterotoxins. Toxins 2010;2:1751-73.  DOI
                   PubMed  PMC
               15.      Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends
                   Microbiol 2018;26:484-97.  DOI  PubMed
               16.      McClelland RS, Fowler VG, Jr. , Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients:
                   comparison of clinical features and mortality. Arch Intern Med 1999;159:1244-7.  DOI
               17.      Miyano T, Irvine AD, Tanaka RJ. Model-based meta-analysis to optimize Staphylococcus aureus-targeted therapies for atopic
                   dermatitis. JID Innov 2022;2:100110.  DOI  PubMed  PMC
               18.      Kobayashi T, Glatz M, Horiuchi K, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis.
                   Immunity 2015;42:756-66.  DOI  PubMed  PMC
               19.      Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with
                   atopic dermatitis. Genome Res 2012;22:850-9.  DOI  PubMed  PMC
               20.      Iwamoto K, Moriwaki M, Miyake R, Hide M. Staphylococcus aureus in atopic dermatitis: strain-specific cell wall proteins and skin
                   immunity. Allergol Int 2019;68:309-15.  DOI  PubMed
               21.      Cogen AL, Yamasaki K, Sanchez KM, et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from
                   staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol 2010;130:192-200.  DOI  PubMed  PMC
               22.      Iwase T, Uehara Y, Shinji H, et al. staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal
                   colonization. Nature 2010;465:346-9.  DOI  PubMed
               23.      Lai Y, Cogen AL, Radek KA, et al. Activation of TLR2 by a small molecule produced by staphylococcus epidermidis increases
                   antimicrobial defense against bacterial skin infections. J Invest Dermatol 2010;130:2211-21.  DOI  PubMed  PMC
               24.      Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat
                   Med 2009;15:1377-82.  DOI  PubMed  PMC
   12   13   14   15   16   17   18   19   20   21   22